Otsuka Pharmaceutical Companies (U.S.)

With Mental Health America, we are humbled to announce the launch of the new Equity Impact Zone (EIZ) grant program designed to address mental health equity gaps within local New Jersey communities.? ? Understanding that factors such as housing, income, food security, safety, and freedom from discrimination are known to be key social drivers of mental health inequity, the mission of the EIZ program is to empower community-based organizations to implement resources tailored to the unique needs of their members. Recipients of the inaugural grants are Young Audiences (YA) New Jersey & Eastern Pennsylvania in Burlington County, and the Mental Health Association of New Jersey (MHANJ) in Trenton.??? ? At Otsuka, we hold a deep respect for the value of every mind. We will not rest until mental illnesses and brain diseases are recognized as chronic diseases that warrant early, equitable, and accessible intervention for patients and caregivers everywhere.? Read more about the recipients: https://bit.ly/486ojUM

Did you know that attention-deficit hyperactivity disorder (ADHD) affects as many as one in every 20 children? While the condition is most often associated with children, there has been a more recent understanding that ADHD may continue into adulthood for many individuals.?? ?? That is why we will not rest until mental illnesses and brain conditions are approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention.?? ?? Learn more about our commitment: https://bit.ly/4duVuCo

This #MentalIllnessAwarenessWeek, we are focusing on bringing awareness to mental illnesses to educate others on the importance of understanding and taking the first step with us.? ?? "As an innovative pharmaceutical company, we know we cannot achieve this as one organization. We must look beyond our own clinical pipelines to collaborate with others who may bring entirely new expertise and mindsets to the table." - Tarek Rabah, President & CEO of Otsuka America Pharmaceutical, Inc.?? ? At Otsuka, we hold a deep respect for the value of every mind. We will not rest until mental illnesses and brain diseases are approached with the same priority and urgency as our physical health and recognized as chronic diseases that warrant early, equitable, and accessible intervention for patients and caregivers everywhere.?? Discover our commitment: https://bit.ly/4duVuCo

Our commitment to patients and their families extends beyond developing treatments; it encompasses emotional, psychological, and practical support to navigate the demanding journey of autosomal dominant polycystic kidney disease (ADPKD) patients. Our patient promise is at the core of everything we do. Read more from Lina Floren Smith, Vice President of Nephrology and Immunology business in the article below.

Today, we are pleased to present, in collaboration with Lundbeck LLC, the 'I Wish I Knew' national public education campaign, featuring Barbara Corcoran, aimed at helping the over 11 million family caregivers of people with Alzheimer's learn more about the symptoms of agitation in Alzheimer's dementia.? Renowned entrepreneur, author, investor and caregiving advocate, Barbara Corcoran bravely shares her family's difficult journey with her mother's Alzheimer's dementia, in hopes that others will benefit from what she wishes she knew when her mother was diagnosed. "These changes felt heartbreaking for my siblings and me to watch, because our mother had never been this way. She was a lovebug. We didn't recognize the agitated person she had become" said Barbara, who lost her mother in 2012. Read more about Barbara's story and the 'I Wish I Knew' campaign: https://lnkd.in/gtHp3aVP

We are thrilled to attend the American Society of Nephrology's Kidney Week 2024 in San Diego and look forward to meeting kidney professionals from around the world. For those registered to attend, we invite you to visit us at Booth #929 and learn more about the autoimmune kidney disease Immunoglobulin A nephropathy (IgA Nephropathy). Our perseverance and long-term commitment in the nephrology space has led to major breakthroughs, giving patients renewed hope and clinicians more options than ever before. Discover our commitment: https://lnkd.in/g3TsScPa #DefyLimitation #KidneyWeek2024?#KidneyWk

We are proud to announce that Jnana Therapeutics is now part of Otsuka Pharmaceutical Co., Ltd. Jnana will continue to be based in Boston and operate as a direct subsidiary of Otsuka America, Inc. We look forward to continuing our mission to develop small molecules against challenging-to-drug targets for under-addressed diseases and advancing JNT-517 into a pivotal Phase 3 study for PKU in early 2025. Read more: https://bit.ly/3ZD6b2q #acquisition #pharmaceuticals #biotechnology

Great Place To Work US and Fortune magazine have selected Otsuka for the 2024 Fortune Best Workplaces in BioPharma? List, ranking at #6.?? ?? This recognition would not be possible without Otsuka-people and their shared commitment to our mission of creating new products for better health worldwide.?? ?? We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care for the communities we serve.?? ?? Learn more about the list here: https://bit.ly/3XDXH9Z

Research has found that nearly half of caregivers in the U.S. who provide care for an older adult do so for someone living with Alzheimer's disease or dementia.? As a healthcare company, Otsuka is continuously gaining a deeper understanding of how the lives of family caregivers are impacted so that we can offer meaningful resources that provide support and alleviate some of the challenges experienced along their unique journeys.? ? Together, we have the potential to improve the future for caregivers if we all do our part.? ? Discover our caregiver commitment: https://bit.ly/4dhcLix

We firmly stand with the World Health Organization in their mission to enhance patient safety globally for World Patient Safety Day.? ?? Patient safety and care is at the core of our purpose.?? From spearheading pioneering research to designing innovative products and healthcare solutions, our commitment to improving health outcomes remains unwavering for the communities we serve.? ?? Let’s continue to prioritize patient safety together for a healthier future.? ?? Learn more about World Patient Safety Day and the critical importance of patient safety: https://bit.ly/3VGfdrW?? ?? #WorldPatientSafetyDay2024 #PatientSafety #WorldHealthOrganization #OtsukaCares